Furthermore, studies have demonstrated that levels of several enzymes—such as HK, enolase (ENO1), PK, lactate dehydrogenase A (LDHA), glucose transporter (GLUT), and hypoxia‐inducible factor 1‐Alpha (HIF1‐α)—are significantly elevated in gastric cancer cells, underscoring their crucial role in glycolytic reprogramming. The gene discussed is LDHA; the disease is gastric cancer.